Bumper Offer - Urjas oil Just @ Rs. 1
Pyrestat, a prescription drug, is manufactured in various forms such as Tablet, Suspension. It is typically used for the treatment of Fever, Pain. Other than this, Pyrestat has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Pyrestat. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Pyrestat as well, which are listed below. Such side effects of Pyrestat normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Pyrestat's effect during pregnancy is Unknown and Unknown while nursing. In addition, Pyrestat's effects on the liver, heart and kidney are discussed below in the Pyrestat related warnings section.
Pyrestat can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Pyrestat in conditions like Liver Disease. Other conditions have been mentioned below in the Pyrestat contraindications section.
Drug interactions for Pyrestat have been reported in the medical literature. See below for a complete list.
You should also be aware that Pyrestat is safe while driving, and is addiction.
Pyrestat is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Pyrestat is used -
Severe
Moderate
Mild
Is the use of Pyrestat safe for pregnant women?
It is not known what effect Pyrestat will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Pyrestat safe during breastfeeding?
No research work has been carried out till date on effect of Pyrestat on breastfeeding women. So it is not known whether taking Pyrestat will cause side effects or not.
What is the effect of Pyrestat on the Kidneys?
Pyrestat may have severe effects on your kidney, so do not take it without consulting your doctor.
What is the effect of Pyrestat on the Liver?
There may be severe side effects of Pyrestat on your liver. Do not take it unless a doctor says so.
What is the effect of Pyrestat on the Heart?
Pyrestat can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Pyrestat should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Pyrestat unless your doctor advises you to do so -
Is this Pyrestat habit forming or addictive?
Pyrestat is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Pyrestat since it does not cause drowsiness.
Is it safe?
Pyrestat should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Pyrestat cannot treat any kind of mental disorder.
Interaction between Food and Pyrestat
There isn't any research available on the side effects of taking Pyrestat with food.
Interaction between Alcohol and Pyrestat
Consult your doctor before consuming alcohol while taking Pyrestat as it can have severe side effects.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 203-204
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 203-204
